Brian W. Nolan is a member of the Intellectual Property group at Mayer Brown. Brian focuses his practice on intellectual property litigation and counseling in the areas of patent, trade secret, unfair competition, antitrust, trademark, counterfeit goods and copyright law. LMG Life Sciences recognized Brian as a “Life Sciences Star” and according to IAM 1000 “…Brian [is an] excellent litigator… who [has] developed leading expertise on litigation involving alleged infringements of the Cabilly patent portfolio.”
Brian has acted as lead and trial counsel on numerous matters covering all aspects of intellectual property protection. Brian has participated in several district court trials, ITC investigations, USPTO Inter Partes Review and appellate proceedings relating to a wide range of technologies, including monoclonal antibodies, pharmaceuticals, receptor pharmacology, medical devices, biotechnology, medical imaging technology, crystal growth, semiconductors, laser diodes, building products, data capture systems and computer storage systems. Additionally, Brian has experience litigating cases brought under the Hatch-Waxman statute and counseling innovator pharmaceutical companies regarding their patent portfolios and potential generic competition prior to patent expiry. Brian has also counseled clients concerning intellectual property issues in business deals.
Brian is an adjunct professor of law at Fordham University School of Law, where he teaches a course on patent litigation. Brian speaks on intellectual property issues at many events, including the Fordham University School of Law Annual Conference on Intellectual Property Law and Policy.